*ST赛隆(002898.SZ)：子公司获得注射用尼可地尔药品注册证书

Core Viewpoint - *ST Sailong (002898.SZ) has recently received approval from the National Medical Products Administration for the injection of Nicorandil, which is indicated for the treatment of unstable angina pectoris [1] Company Summary - The wholly-owned subsidiary of *ST Sailong, Hunan Sailong Pharmaceutical (Changsha) Co., Ltd., has obtained the drug registration certificate for injectable Nicorandil [1]